Talis Biomedical Corporation (TLIS)

NASDAQ: TLIS · IEX Real-Time Price · USD
0.798
+0.028 (3.58%)
At close: Aug 11, 2022 4:00 PM
0.842
+0.044 (5.553%)
Pre-market: Aug 12, 2022 8:00 AM EDT
3.58%
Market Cap 21.23M
Revenue (ttm) 4.84M
Net Income (ttm) -127.13M
Shares Out 26.62M
EPS (ttm) -6.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 309,986
Open 0.760
Previous Close 0.770
Day's Range 0.755 - 0.806
52-Week Range 0.716 - 9.200
Beta n/a
Analysts Sell
Price Target 1.02 (+27.9%)
Earnings Date Aug 8, 2022

About TLIS

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory ... [Read more...]

Industry Medical Devices
IPO Date Feb 12, 2021
Employees 242
Stock Exchange NASDAQ
Ticker Symbol TLIS
Full Company Profile

Financial Performance

In 2021, TLIS's revenue was $8.19 million, a decrease of -25.10% compared to the previous year's $10.94 million. Losses were -$192.04 million, 110.7% more than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for TLIS stock is "Sell." The 12-month stock price forecast is 1.02, which is an increase of 27.87% from the latest price.

Price Target
$1.02
(27.87% upside)
Analyst Consensus: Sell
Stock Forecasts

News

Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results

Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific

Talis Biomedical Announces First Quarter 2022 Financial Results

Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific

Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022

MENLO PARK, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious dise...

Talis Biomedical stock bounces off record low after largest shareholder pulls share-sale plans

Shares of Talis Biomedical Corp. TLIS, +2.34% bounced 1.9% in midday trading Monday, after the diagnostic testing company requested a withdrawal of a large share offering by a selling shareholder. After...

Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific

TLIS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 8, 2022 in the Class Action Filed on Beha...

NEW YORK, March 8, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS) alleging that t...

Deadline Tomorrow Alert: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100...

Los Angeles, California--(Newsfile Corp. - March 7, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Talis Biomedical Co...

TLIS DEADLINE TOMORROW: Hagens Berman, National Trial Attorneys, Alerts Talis Biomedical Corporation (TLIS) Investors...

San Francisco, California--(Newsfile Corp. - March 7, 2022) - Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities cl...

FINAL DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors with Loss...

New York, New York--(Newsfile Corp. - March 7, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Talis Biomedical Corporation (NASDAQ: TLIS) pursuan...

Final Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securitie...

RADNOR, Pa., March 7, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Talis Biomedi...

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Talis Investors of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, March 7, 2022 /PRNewswire/ -- Attention Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced o...

Deadline Tuesday Notice: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100...

Los Angeles, California--(Newsfile Corp. - March 6, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Talis Biomedical Co...

TUESDAY DEADLINE: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Actio...

SAN DIEGO, March 5, 2022 /PRNewswire/ --  Robbins Geller Rudman & Dowd LLP announces that purchasers of Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant and/or traceable to the registra...

Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Talis Biomedical Corporation (TLIS) Investors of Filin...

Radnor, Pennsylvania--(Newsfile Corp. - March 5, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against...

TUESDAY DEADLINE: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Actio...

SAN DIEGO--(BUSINESS WIRE)-- #TLISstock--The suit alleges defendants issued false statements concerning Talis business and prospects, resulting in its stock trading at inflated prices.

TLIS SHAREHOLDER ALERT: Jakubowitz Law Reminds Talis Shareholders Of A Lead Plaintiff Deadline Of March 8, 2022

NEW YORK, March 4, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS). To r...

Deadline Tuesday Alert: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,...

Los Angeles, California--(Newsfile Corp. - March 3, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Talis Biomedical Co...

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Talis Biomedical Corporation with Lea...

RADNOR, Pa.--(BUSINESS WIRE)---- $TLIS--Securities Fraud Class Action Filed Against Talis Biomedical Corporation with Lead Plaintiff Deadline Approaching

TLIS LAWSUIT ALERT: Levi & Korsinsky Notifies Talis Biomedical Corporation Investors of a Class Action Lawsuit and Up...

NEW YORK, March 3, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) of a class action securities lawsuit. CLASS DEF...

Tuesday Deadline Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $1...

Los Angeles, California--(Newsfile Corp. - March 2, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Talis Biomedical Co...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit...

NEW YORK , March 2, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Talis Biomedical Corporation. Shareholders who purchased shares of TLIS during the cl...

CLASS ACTION: Kessler Topaz Meltzer & Check, LLP Reminds Talis Biomedical Corporation Shareholders of Securities Frau...

Radnor, Pennsylvania--(Newsfile Corp. - March 1, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against...

7-Day Deadline Reminder: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100...

Los Angeles, California--(Newsfile Corp. - March 1, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Talis Biomedical Co...

Talis Biomedical to Announce Fourth Quarter and Full Year Financial Results on March 15, 2022

MENLO PARK, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious dise...

NOTICE For Investors In NASDAQ: TLIS: Deadline in Lawsuit Against Talis Biomedical Corporation Announced by Sharehold...

San Diego, California--(Newsfile Corp. - March 1, 2022) - The Shareholders Foundation, Inc. announced that a deadline is coming up in the lawsuit that was filed for certain investors in NASDAQ: TLIS sha...